Genelux CorporationGNLXNASDAQ
Loading
R&D Expenses Over TimeStrong
Percentile Rank100
3Y CAGR+29.8%
5Y CAGR+26.1%
Studio
Year-over-Year Change

Research and development spending

3Y CAGR
+29.8%/yr
Annual compound
5Y CAGR
+26.1%/yr
Recent acceleration
Percentile
P100
Near historical high
vs 5Y Ago
3.2x
Strong expansion
Streak
5 yr
Consecutive growthStrong
PeriodValueYoY Change
2025$19.85M+4.5%
2024$19.00M+48.8%
2023$12.77M+40.6%
2022$9.08M+43.7%
2021$6.32M+1.5%
2020$6.23M-17.3%
2019$7.53M-